Scientific deep-dive

Mounjaro and Muscle Loss: How Much Lean Mass You Lose & How to Protect It (2026)

Does Mounjaro (tirzepatide) cause muscle loss? About 25 to 40% of weight lost on a GLP-1/GIP can be lean mass, but it is largely preventable. How much you lose, why it matters, and how to protect muscle with protein and resistance training — verified against the SURMOUNT trials.

By Eli Marsden · Founding Editor
Editorially reviewed (not clinically reviewed) · How we verify contentLast reviewed
8 min read·6 citations

Yes — some of the weight you lose on Mounjaro is lean (muscle) mass, not just fat. But that is not a unique Mounjaro toxicity: any rapid, large weight loss — from dieting, bariatric surgery, or a GLP-1/GIP medication — strips away both fat and muscle, because the body draws on lean tissue when it is in a sizeable calorie deficit.[3] Mounjaro is tirzepatide, the same molecule sold for weight management as Zepbound, and it produces greater average total weight loss than semaglutide — about 21 percent of body weight at the top dose over 72 weeks in the SURMOUNT-1 obesity trial.[1] In the body-composition sub-analysis of that same trial and in reviews that pool the GLP-1 data, roughly 25 to 40 percent of total weight lost can come from lean mass — broadly in line with what is expected for the amount of weight lost, not evidence that the drug "melts muscle."[2][3] The genuinely important part is that this lean-mass loss is largely preventable: getting enough protein, doing resistance (strength) training, and not losing weight faster than necessary all substantially blunt it in randomized trials.[3][4][5] This guide explains how much muscle you actually lose, why it matters, who is most at risk, and exactly how to protect your lean mass. See our Mounjaro drug page and our companion guide on muscle loss on semaglutide. This is general educational information, not medical advice — your prescriber manages your care.

About this article

The body-composition figures below are drawn from the pivotal tirzepatide obesity trial (SURMOUNT-1) and its DEXA body-composition sub-analysis, which measured fat and lean (fat-free) mass changes, and from a peer-reviewed review of strategies to minimize muscle loss during incretin-mimetic (GLP-1) therapy. The protein and resistance-training guidance is drawn from randomized controlled trials and a sports-nutrition position stand on diet and body composition during energy deficit. We describe lean-mass loss as a normal physiologic consequence of large calorie deficits — common to diet, surgery, and incretin drugs alike — rather than a unique drug toxicity, and we treat any single percentage as approximate because measured lean-mass loss varies by trial, by how it is measured (DEXA versus MRI), by the rate of weight loss, and by protein intake and activity. Any muscle-preserving drug combinations we mention are clearly flagged as investigational, not approved. For dosing and access details see the Mounjaro drug page, and compare the pattern on semaglutide in muscle loss on semaglutide. This is general information, not medical advice — your prescriber individualizes your care.

Does Mounjaro cause muscle loss?

Some muscle loss happens with Mounjaro, but the framing matters. Mounjaro (tirzepatide) does not have a direct toxic action that targets and destroys muscle. What it does is produce substantial weight loss — in the SURMOUNT-1 trial, adults with obesity lost on average up to about 21 percent of body weight on tirzepatide over 72 weeks, a larger average reduction than is typically seen with semaglutide.[1] Whenever the body sheds weight that quickly, it draws on both fat and lean tissue, and lean tissue includes skeletal muscle. This is the same pattern seen with very-low-calorie diets and with bariatric surgery — it is a consequence of the calorie deficit and the rate of weight loss, not something unique to GLP-1/GIP drugs.[3]

So the honest answer is: yes, you lose some muscle, but it is mostly a side effect of losing weight fast, not of the drug poisoning your muscles — and that distinction is what makes it addressable. Because tirzepatide drives more total weight loss on average, there is simply more total tissue moving, which is one reason lean-mass preservation is worth taking seriously on it. But the lean-mass loss still tracks the calorie deficit, so the same things that protect muscle during any diet (enough protein, strength training, a sensible rate of loss) protect it on Mounjaro too.[2][3] Headlines like "Mounjaro melts muscle" overstate the case; the measured lean-mass losses in the SURMOUNT body-composition data were broadly proportional to the weight lost, with fat making up the larger share, and they can be meaningfully reduced.[2][3]

How much lean mass do you actually lose?

When researchers use body-composition scans (DEXA or MRI) to break down weight loss into fat versus lean tissue, a consistent picture emerges across the tirzepatide and semaglutide trials and the reviews that pool them: somewhere around one quarter to two fifths of the total weight lost is lean mass, with the remainder being fat.[2][3] In the SURMOUNT-1 body-composition sub-analysis, tirzepatide reduced both fat mass and lean (fat-free) mass, with fat accounting for the majority of the loss and the ratio of fat to lean loss broadly favorable — roughly what is expected when someone loses a large amount of weight regardless of method.[1][2]

Two caveats keep this honest. First, "lean mass" on a scan is not all muscle — it includes water, glycogen, connective tissue, and organ mass, so a 30 percent lean-mass figure does not mean 30 percent of your weight loss was functional muscle. Second, the percentage is highly modifiable: in studies where people ate adequate protein and did resistance training during weight loss, the share lost as lean mass dropped substantially, and some trained, high-protein participants preserved or even gained muscle while losing fat.[4][5] The number is a starting point you can shift, not a fixed tax — and that holds whether you are on tirzepatide or semaglutide.

Magnitude comparison

Where the weight goes on tirzepatide — roughly 60 to 75 percent of total weight lost is fat, while about 25 to 40 percent can be lean (including muscle) mass. Because Mounjaro drives larger average weight loss, the total tissue moving is greater, so pushing the lean-mass share down toward the bottom of that range with adequate protein and resistance training matters. Figures are approximate and vary by trial, measurement method, rate of loss, protein intake, and activity.[2][3]

  • Fat mass lost (the goal)67 % of weight lost
    the majority of weight lost
  • Lean (incl. muscle) mass lost — typical33 % of weight lost
    ~25-40% range
  • Lean mass lost — with protein + resistance training15 % of weight lost
    substantially blunted in trials
Where the weight goes on tirzepatide — roughly 60 to 75 percent of total weight lost is fat, while about 25 to 40 percent can be lean (including muscle) mass. Because Mounjaro drives larger average weight loss, the total tissue moving is greater, so pushing the lean-mass share down toward the bottom of that range with adequate protein and resistance training matters. Figures are approximate and vary by trial, measurement method, rate of loss, protein intake, and activity.

Why losing muscle matters

Fat loss is the goal; muscle loss is the collateral damage worth limiting. Muscle is metabolically active and functionally important, so preserving it during weight loss protects several things at once:

  • Metabolic rate. Skeletal muscle is a major contributor to resting energy expenditure. Losing muscle lowers the number of calories you burn at rest, which can make long-term weight maintenance harder once you stop or stabilize on the medication.[3]
  • Strength and physical function. Muscle is what lets you climb stairs, carry groceries, and get up from a chair. Disproportionate muscle loss can leave you lighter but weaker, with reduced functional capacity.[3]
  • Sarcopenia risk in older adults. Older adults already lose muscle with age (sarcopenia), and stacking rapid weight-loss-related muscle loss on top of that can meaningfully erode strength, mobility, and independence. This is why protecting lean mass is especially important past midlife — and especially on a drug that produces larger weight loss.[3]
  • Long-term weight maintenance. Because muscle helps drive metabolic rate and supports the activity that burns calories, preserving it makes it easier to keep weight off rather than regaining fat after weight loss.[3]
  • Bone and metabolic health. Muscle and resistance exercise also support bone density and glucose handling, so the strategies that protect muscle tend to protect these too.[5]

How to protect lean mass on Mounjaro

This is the actionable core. The same evidence-based levers that preserve muscle during any weight loss apply on Mounjaro — and they work. Trials that combined adequate protein with resistance training during an energy deficit consistently preserved far more lean mass than diet alone.[3][4][5] All of the following are general strategies to discuss with your prescriber or a registered dietitian; do not change your Mounjaro dose or other medications on your own.

  1. Eat adequate protein — roughly 1.2 to 1.6 g per kg of body weight per day. Higher protein intake during a calorie deficit is one of the best-established ways to preserve fat-free mass; sports-nutrition guidance and weight-loss trials put the helpful range around 1.2 to 1.6 g/kg/day (and sometimes higher for very active or older people), individualized to your body and kidney status. Tirzepatide's strong appetite suppression makes it easy to fall short, so make protein a deliberate priority at each meal.[4][5][6]
  2. Do resistance (strength) training 2 to 3 times per week. Lifting weights, resistance bands, or bodyweight strength work is the single most direct stimulus telling your body to keep muscle. In trials, combining resistance training with a calorie deficit preserved — and in some high-protein, trained groups even increased — lean mass while fat dropped. Two to three sessions a week covering the major muscle groups is a reasonable, evidence-aligned target.[4][5]
  3. Don't lose weight faster than necessary. The faster and larger the deficit, the more lean mass tends to go with the fat — a point that matters more on tirzepatide because of its larger average weight loss. A steadier rate of loss, supported by the standard slow dose titration, gives your muscle-preserving habits time to work and reduces the lean-mass share.[3]
  4. Keep overall nutrition adequate despite appetite suppression. Mounjaro blunts hunger strongly, which can quietly drop your total intake of protein, calories, and micronutrients below what muscle maintenance needs. Eat regular, balanced, protein-forward meals even when you are not hungry, and consider working with a dietitian if you are struggling to eat enough.[3]
  5. Stay active overall and protect sleep and recovery. General activity, sufficient protein spread across the day, and adequate sleep all support muscle retention and the training stimulus, rounding out the core protein-plus-resistance-training strategy.[5]

A note on muscle-preserving drugs

Some research is exploring investigational drug combinations intended to preserve or build muscle during incretin-driven weight loss — for example, pairing a GLP-1 or GLP-1/GIP drug with an agent such as bimagrumab (an activin-receptor antibody) or other myostatin-pathway drugs being studied in trials. These are not FDA-approved for this purpose, their long-term safety and benefit are unproven, and they are not part of standard care. For now, the established, evidence-backed way to protect muscle on Mounjaro remains adequate protein plus resistance training — not an additional drug. Treat anything beyond that as experimental and discuss it only with your prescriber.

Who is most at risk of muscle loss?

Everyone losing weight loses some lean mass, but a few groups lose proportionally more and have more to lose by it. If you fall into one of these, the protein-and-resistance-training plan is not optional — it is the priority:

  • Older adults. Age-related muscle loss (sarcopenia) means older adults start with less reserve, lose muscle more readily, and feel the functional consequences sooner. Protecting lean mass matters most in this group.[3]
  • People with low protein intake. If appetite suppression has cut your protein well below the ~1.2 to 1.6 g/kg/day range, you are giving your body little raw material to maintain muscle, and lean-mass loss accelerates.[4][6]
  • Sedentary people who do no resistance training. Without a strength stimulus, the body has less reason to hold onto muscle during a deficit, so the lean-mass share of weight lost runs higher.[5]
  • People losing weight very rapidly. Faster, larger deficits pull proportionally more from lean tissue — and because tirzepatide can drive especially large weight loss, very rapid responders should be especially attentive to protein and training.[3]
  • People who are already frail or have low muscle mass. Those with sarcopenic obesity or limited mobility have the least reserve and the most to lose functionally, making muscle preservation a central goal of their plan.[3]

The encouraging counterpoint is that resistance training and adequate protein substantially blunt lean-mass loss across these groups in trials — even older and previously sedentary people retain more muscle when they add strength work and protein during weight loss.[4][5] For the parallel picture on semaglutide, see our guide to muscle loss on semaglutide, and if you are choosing where to start or continue under proper supervision, a good provider will pair the medication with guidance on protein and activity rather than the prescription alone. See the Mounjaro drug page for dosing and access details.

References

  1. 1.Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) — pivotal randomized trial reporting mean body-weight reductions up to ~20.9% on tirzepatide over 72 weeks; basis for the magnitude of weight loss that drives body-composition change. New England Journal of Medicine. 2022. https://pubmed.ncbi.nlm.nih.gov/35658024/
  2. 2.Look M, Dunn JP, Kushner RF, et al. Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight — DEXA sub-analysis reporting reductions in both fat mass and lean (fat-free) mass with weight loss. Diabetes, Obesity and Metabolism. 2025. https://pubmed.ncbi.nlm.nih.gov/39996356/
  3. 3.Mechanick JI, Butsch WS, Christensen SM, et al. Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity — review of the magnitude of lean-mass loss with GLP-1 therapy and the evidence-based countermeasures (protein, resistance training, rate of loss). Obesity Reviews. 2025. https://pubmed.ncbi.nlm.nih.gov/39295512/
  4. 4.Longland TM, Oikawa SY, Mitchell CJ, et al. Higher compared with lower dietary protein during an energy deficit combined with intense exercise promotes greater lean mass gain and fat mass loss: a randomized trial. American Journal of Clinical Nutrition. 2016. https://pubmed.ncbi.nlm.nih.gov/26817506/
  5. 5.Pasiakos SM, Cao JJ, Margolis LM, et al. Effects of high-protein diets on fat-free mass and muscle protein synthesis following weight loss: a randomized controlled trial. FASEB Journal. 2013. https://pubmed.ncbi.nlm.nih.gov/23739654/
  6. 6.Aragon AA, Schoenfeld BJ, Wildman R, et al. International Society of Sports Nutrition position stand: diets and body composition — guidance on protein intake (~1.2-1.6+ g/kg/day) and resistance training to preserve lean mass during energy deficit. Journal of the International Society of Sports Nutrition. 2017. https://pubmed.ncbi.nlm.nih.gov/28630601/

Where to get tirzepatide (Mounjaro / Zepbound): vetted providers

Vetted telehealth providers that prescribe online, ranked by our editorial score. We compare pricing, form, and states served.

No insurance needed · vetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.3

Breeze Meds

Compounded GLP-1 access with named prescribers and 4-pharmacy network

8.6

Enhance MD

Lab-monitored compounded GLP-1 with mandatory video visit

8.5

Embody

Lowest first-month entry pricing on compounded GLP-1s